Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREATE rosuvastatin trial in low-risk chest pain patients
2006-001860-22Phase 4Completed
- Sponsor
- Karl Andersen
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin in cardiac event risk (2 arms), sponsored by Karl Andersen. Primary endpoint: Suppression of inflammatory markers. Started Jul 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
cardiac event risk
Beyond the preview
Go deeper on 2006-001860-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001860-22.